Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 618K - 618K
Notice Type:
Contract award notice
Published Date:
07 January 2020
Closing Date:
Location(s):
ES ESPAÑA (ES Spain/ESPAÑA)
Description:
Suministro de medicamentos exclusivos: Amfotericina B, Idelalisisb, Sofosbuvir, Velpatasvir, Voxilaprevir

Medicamentos exclusivos: Amfotericina B, Idelalisisb, Sofosbuvir, Velpatasvir, Voxilaprevir.


Amfotericina B 50 mg (10 viales)

Amfotericina B, 50 mg (10 viales).


Idelalisisb, 100 mg (60 comprimidos)

Idelalisisb, 100 mg (60 comprimidos).


Idelalisisb, 150 mg (60 comprimidos)

Idelalisisb, 150 mg (60 comprimidos).


Sofosbuvir, Velpatasvir, Voxilaprevir, 400/100/100 mg (28 comprimidos)

Sofosbuvir, Velpatasvir, Voxilaprevir, 400/100/100 mg (28 comprimidos).

Awarded to:
Amfotericina B, 50 mg (10 viales)
Gilead Sciences, S. L., Madrid (ES)
Idelalisisb, 100 mg (60 comprimidos)
Gilead Sciences, S. L., Madrid (ES)
Idelalisisb, 150 mg (60 comprimidos)
Gilead Sciences, S. L., Madrid (ES)
Sofosbuvir, Velpatasvir, Voxilaprevir, 400/100/100 mg (28 comprimidos)
Gilead Sciences, S. L., Madrid (ES)
Download full details as .pdf
The Buyer:
Área Sanitaria IV, Hospital Universitario Central de Asturias
CPV Code(s):
33600000 - Pharmaceutical products